The Thiol-Modifier Effects of Organoselenium Compounds and Their Cytoprotective Actions in Neuronal Cells
- 31 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurochemical Research
- Vol. 46 (1), 120-130
- https://doi.org/10.1007/s11064-020-03026-x
Abstract
Most pharmacological studies concerning the beneficial effects of organoselenium compounds have focused on their ability to mimic glutathione peroxidase (GPx). However, mechanisms other than GPx-like activity might be involved on their biological effects. This study was aimed to investigate and compare the protective effects of two well known [(PhSe)(2) and PhSeZnCl] and two newly developed (MRK Picolyl and MRK Ester) organoselenium compounds against oxidative challenge in cultured neuronal HT22 cells. The thiol peroxidase and oxidase activities were performed using the glutathione reductase (GR)-coupled assay. In order to evaluate protective effects of the organoselenium compounds against oxidative challenge in neuronal HT22 cells, experiments based on glutamate-induced oxytosis and SIN-1-mediated peroxynitrite generation were performed. The thiol peroxidase activities of the studied organoselenium compounds were smaller than bovine erythrocytes GPx enzyme. Besides, (PhSe)(2) and PhSeZnCl showed higher thiol peroxidase and lower thiol oxidase activities compared to the new compounds. MRK Picolyl and MRK Ester, which showed lower thiol peroxidase activity, showed higher thiol oxidase activity. Both pre- or co-treatment with (PhSe)(2), PhSeZnCl, MRK Picolyl and MRK Ester protected HT22 cells against glutamate-induced cytotoxicity. (PhSe)(2) and MRK Picolyl significantly prevented peroxinitrite-induced dihydrorhodamine oxidation, but this effect was observed only when HT22 were pre-treated with these compounds. The treatment with (PhSe)(2) increased the protein expression of antioxidant defences (Prx3, CAT and GCLC) in HT22 cells. Taking together, our results suggest that the biological effects elicited by these compounds are not directly related to their GPx-mimetic and thiol oxidase activities, but might be linked to the up-regulation of endogenous antioxidant defences trough their thiol-modifier effects.Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (401065/204-6, 424809/2018-4)
- FAPDF (712/2019)
This publication has 33 references indexed in Scilit:
- Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat modelEuropean Journal of Pharmacology, 2016
- Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insightBiomedicine & Pharmacotherapy, 2015
- Diphenyl-diselenide suppresses amyloid-β peptide in Caenorhabditis elegans model of Alzheimer’s diseaseNeuroscience, 2014
- Protective effect of diphenyl diselenide against peroxynitrite-mediated endothelial cell death: A comparison with ebselenNitric Oxide, 2013
- Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compoundsArchives of Toxicology, 2011
- Diphenyl diselenide a janus-faced moleculeJournal of the Brazilian Chemical Society, 2010
- Selective neuronal vulnerability to oxidative stress in the brainFrontiers in Aging Neuroscience, 2010
- Glutathione Peroxidase Protects against Peroxynitrite-mediated OxidationsOnline Journal of Public Health Informatics, 1997
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- Glutathione peroxidase: A selenoenzymeFEBS Letters, 1973